Philadelphia-based startup BioBots has unveiled an innovative system designed to revolutionize rapid bio-prototyping. This new fabrication station aims to significantly reduce the time and cost associated with developing replacement organs.
The BioBot rapid bio-prototyping fabrication station, developed by BioBots, is poised to make a substantial impact in the field of medical science. By leveraging advanced technology, BioBots is addressing the critical shortage of organs available for transplantation. This innovative system uses ‘Blue Light Technology’ or UV energy to cure biomaterials rapidly without damaging cells. According to the company, these biomaterials mimic the architecture of the extracellular matrix in which cells are suspended, and the cells themselves can be incorporated into these constructs.
Innovative Technology and Applications
The technology behind BioBots is roughly analogous to a method used three years ago that relied on a 3D printer to create the scaffolding of a larynx, upon which new cells were grown. This method demonstrated the potential for 3D printing in medical applications, and BioBots has taken this concept further by developing a more efficient and versatile system.
BioBots’ fabrication station is not only capable of creating scaffolds for organs but also allows for the incorporation of living cells into these structures. This capability opens up a wide range of possibilities for medical research and treatment. For example, researchers can use the BioBots system to create tissue models for drug testing, reducing the need for animal testing and accelerating the development of new medications. Additionally, the ability to print complex tissue structures could lead to breakthroughs in regenerative medicine, where damaged tissues and organs can be repaired or replaced with bio-printed alternatives.
Support and Recognition
BioBots was founded by UPenn graduates Danny Cabrera and Ricardo Solorzano. The startup has garnered significant support and recognition in the tech and medical communities. BioBots has received backing from Ben Franklin Technology Partners and has been a part of the DreamIt Health Incubator. The company is also in the running to win the Digital Health and Life Sciences Technologies category for the 7th annual SXSW Accelerator competition.
The support from these organizations highlights the potential impact of BioBots’ technology. Ben Franklin Technology Partners, for instance, is known for investing in innovative startups with the potential to drive economic growth and create high-quality jobs. Being part of the DreamIt Health Incubator has provided BioBots with valuable resources and mentorship to help accelerate their development and bring their technology to market.
For more information on the new BioBots rapid bio-prototyping fabrication station, visit the BioBots website for details.
Source: SolidSmack : BioBots
Latest Geeky Gadgets Deals
Disclosure: Some of our articles include affiliate links. If you buy something through one of these links, Geeky Gadgets may earn an affiliate commission. Learn about our Disclosure Policy.
